Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)
Anemia, Mortality
About this trial
This is an interventional prevention trial for Anemia focused on measuring ESRD, Anemia, Hospitalizations, Mortality
Eligibility Criteria
Inclusion Criteria:
- age ≥ 18
- resumption of routine outpatient chronic hemodialysis within three days of discharge from hospital admission
- enrolled in a facility-based anemia management program
Exclusion Criteria:
- enrolled in hospice
- previous hospitalization within the past 30 days (ie. patients discharged from a repeat hospitalization)
- anticipated discharge from the outpatient dialysis facility within 30 days (ie anticipated transfer to another facility or hospice)
Sites / Locations
- Denver Central
- St. John's
- JAX Beach
- Prairie
- Tri Counties
- Huntington
- Floyd County
- South Louisville
- Breaux Bridge
- Delta
- East Lafayette
- Methuen
- Roxbury
- Battle Creek
- East Lansing
- Oshtemo
- Lansing
- Saganaw Riverside
- Saginaw
- Eupora
- Meridian
- Yokna River
- Independence Centerpoint
- Desert Inn
- South Pecos
- Briggs Ave
- Freedom Lake
- Boardman
- Cortland
- Elyria
- North Randall
- Westlake
- Willoughby
- Twin Oaks
- Clackamas
- Fresenius Medical Services
- Smyrna
- West Nashville
- North Fort Worth
- Tarrant County
- Waco
- Waco West
Arms of the Study
Arm 1
Arm 2
Other
Other
Early anemia management
case control
Upon return to the dialysis unit following hospitalization, patients will be immediately identified and have immediate implementation of the unit anemia protocol rather than waiting for the next regularly scheduled unit labs and regular follow-up. Thus, labs will be obtained within the first 3-7 days following hospitalization and appropriate titration of Epo and iron medications within the 7 days after discharge from hospital and under the direction of the pre-specified algorithm used in the patient's facility; all drug dosing will comply with package insert instructions
Each case will be "data-matched" to an intra-facility (primary control), and then an inter-facility (validation control) control patient. Matching criteria will be by age, gender, diabetic status, attending nephrologist, length of hospitalization stay, and hospital discharge date (to minimize the difference in the date between the case and control). These patients did not have early intervention but followed the usual practice of waiting for the next regularly scheduled dialysis unit labs with anemia management to follow using the regular unit algorithm.